Blog
RSS FeedPosted by Michael Wonder on 14 May 2018
President Donald Trump wants to build a drug cartel – and wants New Zealand to pay for it
13 May 2018 - Accusing other countries of "freeloading", US President Donald Trump has announced plans to make countries like ...
Posted by Michael Wonder on 14 May 2018
Jacinda Ardern: PHARMAC will be protected in trade deals after Trump threats
12 May 2018 - Prime Minister Jacinda Ardern has assured New Zealanders that PHARMAC will be protected in future trade ...
Posted by Michael Wonder on 14 May 2018
Decision to widen access and change the funded brand of tenofovir disoproxil and entecavir
14 May 2018 - PHARMAC is pleased to announce decisions to approve agreements with Teva Pharma New Zealand Limited and ...
Posted by Michael Wonder on 13 May 2018
Can Donald Trump really change the cost of New Zealand drugs?
13 May 2018 - In a speech announcing "the most sweeping action in history to lower prices for prescription drugs ...
Posted by Michael Wonder on 12 May 2018
Decision to fund mercaptopurine oral suspension
10 May 2018 - PHARMAC is pleased to announce the approval of an agreement with Link Pharmaceuticals Limited for the ...
Posted by Michael Wonder on 10 May 2018
The Kiwi patients that New Zealand's health system won't help
10 May 2018 - Freda Evans was blocked by security before she could get to the then Prime Minister, John ...
Posted by Michael Wonder on 10 May 2018
Thousands of New Zealanders will benefit from advances in treatment
10 May 2018 - Thousands of New Zealanders will benefit from advances in treatment as a result of two PHARMAC ...
Posted by Michael Wonder on 08 May 2018
Notification of delay of decision on denosumab funding proposal
8 May 2018 - PHARMAC would like to advise all interested parties that there will be a delay in the ...
Posted by Michael Wonder on 07 May 2018
Reality TV star John 'Cocksy' Cocks' brave battle with terminal cancer
5 May 2018 - Cocksy had radiation for the last time in early January but can't have more as the ...
Posted by Michael Wonder on 04 May 2018
Decision to fund aflibercept and rivaroxaban
3 May 2018 - PHARMAC is pleased to announce the approval of an agreement with Bayer New Zealand Limited for ...
Posted by Michael Wonder on 30 Apr 2018
New Zealand Pharmaceutical Schedule - 1 May 2018
1 May 2018 - The May 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Apr 2018
Fight over PHARMAC's switch to generic anti-depressant brand continues
27 April 2018 - Depression sufferers wanting to remain on old anti-depressant brand can – but at a cost. ...
Posted by Michael Wonder on 23 Apr 2018
'They make a difference' - modern medicines not being funded for Kiwis, industry group says
20 April 2018 - Nearly a quarter of a million Kiwis are missing out on the latest in modern medicine, Medicine ...
Posted by Michael Wonder on 18 Apr 2018
Terminally ill dad saves more than $200k bringing in cancer drugs from India
17 April 2018 - A Kiwi dad who's dying of lung cancer has been bypassing the PHARMAC system to get ...
Posted by Michael Wonder on 09 Apr 2018
Proposal to remove the funding restrictions for candesartan
9 April 2018 - Following assessment of bids in PHARMAC’s 2017/18 annual Invitation to Tender, PHARMAC is proposing to remove ...